Hypolipidemic effects of lactic acid bacteria fermented cereal in rats

Lipids in Health and Disease

Volumn 11, Issue , 2012, Pages

  Banjoko, Immaculata Oyeyemi ^a   Adeyanju, Muinat Moronke ^a   Ademuyiwa, Oladipo ^b   Adebawo, Olugbenga Obajimi ^c   Olalere, Rahman Abiodun ^a   Kolawole, Martin Oluseye ^a   Adegbola, Ibrahim Akorede ^a   Adesanmi, Tope Adebusola ^a   Oladunjoye, Tosin Oluyinka ^a   Ogunnowo, Adeyemi Adeola ^a   Shorinola, Ahmeed Adekola ^a   Daropale, Oluwasetemi ^a   Babatope, Esther Bunmi ^a   Osibogun, Adeboye Olufemi ^a   Ogunfowokan, Deborah Tolulope ^a   Jentegbe, Temitope Adeola ^a   Apelehin, Tinuola Gbemi ^a   Ogunnowo, Oluwaseyi ^a   Olokodana, Oluwanifemi ^a   Fetuga, Falilat Yetunde ^a   Omitola, Morenike ^a   Okafor, Linda Adugo ^a   Ebohon, Catherine Lohi ^a   Ita, James Oluwafemi ^a   Disu, Kazeem Ayoola ^a   Ogherebe, Omokaro ^a   Eriobu, Stella Uche ^a   Bakare, Anthony Alaba ^a   more..

^a OLABISI ONABANJO UNIVERSITY   (Nigeria)

^b FEDERAL UNIVERSITY OF AGRICULTURE   (Nigeria)

^c BABCOCK UNIVERSITY   (Nigeria)

Author keywords

Cereals; Dyslipidemia; Fermentation; Lactic acid bacteria; Probiotics

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LIPOPROTEIN; PHOSPHOLIPID; PROBIOTIC AGENT; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BIFIDOBACTERIUM BIFIDUM; CEREAL; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONSTIPATION; CONTROLLED STUDY; DIET; DYSLIPIDEMIA; ENZYME ACTIVITY; ERYTHROCYTE; FERMENTATION; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS HELVETICUS; LIPID DIET; LIPIDOSIS; MAIZE; NONHUMAN; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; BIFIDOBACTERIUM; CEREALS; DIET, HIGH-FAT; DYSLIPIDEMIAS; FERMENTATION; FOOD ANALYSIS; HYPOLIPIDEMIC AGENTS; LACTIC ACID; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS HELVETICUS; LIPIDS; RATS;

ANIMALIA; BIFIDOBACTERIUM BIFIDUM; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS HELVETICUS; RATTUS; ZEA MAYS;

EID: 84870711991     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-11-170     Document Type: Article

References (36)

1. Potential uses of probiotics in clinical practice. Reid G, Jass J, Sebulsky MT, McCormick JK, Clin Microbiol Rev 2003 16 658 672 10.1128/CMR.16.4.658-672.2003 14557292 (Pubitemid 37296554)
2. Efficacy of Lactobacillus rhamnosus GG in acute watery diarrhoea of Indian children: a randomised controlled trial. Basu S, Chatterjee M, Ganguly S, Chandra PK, Paed Child Health 2007 43 837 842 10.1111/j.1440-1754.2007.01201.x (Pubitemid 350150844)
3. Anticarcinogenic and immunological properties of dietary lactobacilli. Fernandes CF, Shahani KM, J Food Prot 1990 53 704 710
4. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Gill HS, Rutherfurd KJ, Cross ML, Gopal PK, Am J Clin Nutr 2001 74 833 839 11722966 (Pubitemid 33101806)
5. Effects of Lactobacillus acidophilus 43121 and a mixture of Lactobacillus casei and Bifidobacterium longum on the serum cholesterol level and fecal sterol excretion in hypercholesterolemia-induced pigs. Park YH, Kim JG, Shin YW, Kim HS, Kim YJ, Chun T, Kim SH, Whang KY, Biosci Biotechnol Biochem 2008 72 595 600 10.1271/bbb.70581 18256473 (Pubitemid 351353678)
6. Lactic acid bacteria affect serum cholesterol levels, harmful fecal enzyme activity, and fecal water content. Lee DK, Jang S, Baek EH, Kim MJ, Lee KS, Shin HS, Chung MJ, Kim JE, Lee KO, Ha NJ, Lipids Health Dis 2009 8 21 10.1186/1476-511X-8-21 19515264
7. Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study. Law MR, Wald NJ, Wu T, Hackshaw A, Bailey A, Bri Med J 1994 308 6925 363 366 10.1136/bmj.308.6925.363
8. The pathogenesis of atherosclerosis: a perspective for 1990s. Ross R, Nature 1993 362 801 809 10.1038/362801a0 8479518 (Pubitemid 23132154)
9. Oral administration of Lactobacillus induces cardioprotection. Oxman T, Shapira M, Klein R, Avazov N, Rabinowitz B, J Altern Complement Med 2001 7 4 345 354 10.1089/107555301750463224 11558777 (Pubitemid 32823783)
10. Cholesterol-lowering effect of probiotic yogurt in comparison with ordinary yogurt in mildly to moderately hypercholeserolemic subjects. Ataie-Jafari A, Larijani B, Alavi Majd H, Tahbaz F, Annals Nutr Metab 2009 54 22 27 10.1159/000203284
11. Probiotics: A critical review of their potential role as anti-hypertensives, immune modulators, hypocholesterolemics, and perimenopausal treatments. Liong MT, Nutr Rev 2007 65 316 328 10.1111/j.1753-4887.2007.tb00309. x 17695372
12. Effect of a dietary inclusion of Lactobacillus acidophilus ATCC43121 on cholesterol metabolism. Heon PY, Kim JG, Shin YW, Kim SH, Whang KY, J Microbiol Biotech 2007 17 4 655 662 (Pubitemid 46739132)
13. In vitro study of bile salt hydrolase (BSH) activity of BSH isogenic Lactobacillus plantarum 80 strains and estimation of cholesterol lowering through enhanced BSH activity. De Smet I, Van Hoorde L, De Saeyer N, Vande Woestyne M, Verstraete W, Microb Ecol Health D 1994 7 315 329 10.3109/08910609409141371
14. Cholesterol lowering in pigs through enhanced bacterial bile salt hydrolase activity. De Smet I, De Boever P, Versteaete W, Brit J Nutr 1998 79 185 194 10.1079/BJN19980030 9536863 (Pubitemid 28081869)
15. Bile salt deconjugation ability, bile salt hydrolase activity and cholesterol coprecipitation ability of lactobacilli strains. Liong MT, Shah NP, Internat Dairy J 2005 15 391 398 10.1016/j.idairyj.2004.08.007 (Pubitemid 40118266)
16. Characterisation and selection of probiotic lactobacilli for a preliminary minipig feeding trial and their effect on serum cholesterol levels, faeces pH and faeces moisture content. du Toit M, Franz CMAP, Dicks LMT, Schillinger U, Haberer P, Warlies B, Ahrens F, Holzapfel WH, Int J Food Microbiol 1998 40 93 104 10.1016/S0168-1605(98)00024-5 9600615 (Pubitemid 28185198)
17. Effects of a ferment soy product on the adipocyte area reduction and dyslipidemia control in hypercholesterolemic adult male rats. Cheik NC, Rossi EA, Guerra RLF, Tenorio NM, Nascimento CM Od, Viana FP, Manzoni MSJ, Carlos IZ, Da-Silva PL, Vendramini RC, Damaso AR, Lipids Health Dis 2008 7 50 10.1186/1476-511X-7-50 19087298
18. Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. Xiao JZ, Kondo S, Takahashi N, Miyaji K, Oshida K, Hiramatsu A, Iwatsuki K, Kokubo S, Hosona A, J Dairy Sci 2000 86 2452 2461 (Pubitemid 39001266)
19. Effects of a novel fermented soy product on the serum lipids of hyper-cholesterolemic rabbits. Rossi EA, Vendramini RC, Carlos IZ, Ueiji IS, Squinzari MM, Silva I Jr, Valdez GF, Arq Bras Cardiol 2000 74 213 216 10.1590/S0066-782X2000000300003
20. Effects of lactobacillus fermented soymilk and soy yogurt on hepatic lipid accumulation in rats fed on a cholesterol-free diet. Kitawaki R, Nishimura Y, Takagi N, Iwasaki M, Tsuzuki K, Fukuda M, Biosci Biotechnol Biochem 2009 73 7 1484 1488 10.1271/bbb.80753 19584552
21. The effect of a probiotic on fecal and liver lipid classes in rats. Fukushima M, Nakano M, Brit J Nutr 1995 73 701 710 10.1079/BJN19950074 7626589
22. Plasmid profiles and antibiotic susceptibility patterns of Lactobacillus isolated from fermented foods in Nigeria. Olukoya DK, Ebigwei SI, Adebawo OO, Osiyemi FO, Food Microbiol 1993 10 279 285 10.1006/fmic.1993.1032
23. Characterization and distribution of lactic acid bacteria in cassava fermentation during fufu production. Oyewole OB, Odunfa SA, J Appl Bacteriol 1990 68 145 152 10.1111/j.1365-2672.1990.tb02559.x (Pubitemid 20129663)
24. A separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. Gidez LI, Miller GJ, Burstein M, Slagle S, Eder HA, J Lipid Res 1982 23 1206 1223 7175378 (Pubitemid 13187618)
25. A simple method for the isolation and purification of total lipids from animal tissues. Folch J, Lees M, Sloane GH, J Biol Chem 1957 226 497 509 13428781
26. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Stewart JCM, Anal Biochem 1980 104 10 14 10.1016/0003-2697(80) 90269-9 6892980 (Pubitemid 10045896)
27. Multiple indexes of lipid availability are independently related to whole body insulin action in healthy humans. Kriketos AD, Furler SM, Gan SK, Poynten AM, Chisholm DJ, Campbell LV, J Clin Endocr Met 2003 88 2 793 798 10.1210/jc.2002-020848 (Pubitemid 36207824)
28. Indirect assessment of hydroxymethylglutaryl-CoA (HMG-CoA) reductase activity in liver tissue. Rao V, Ramakrishnan S, Clin Chem 1975 21 10 1523 1525 1157326
29. Regulation of aspartokinase in Lactobacillus plantarum. Adebawo OO, Ruiz Barba JL, Warner PJ, Oguntimehin GBO, J Appl Microbiol 1997 82 191 196 12452593 (Pubitemid 27226933)
30. Lead-induced phospholipidosis and cholesterogenesis in rat tissues. Ademuyiwa O, Agarwal R, Chandra R, Behari JR, Chem Biol Interact 2009 179 314 320 10.1016/j.cbi.2008.10.057 19056365
31. Metabolism of acylglycerols and sphingolipids. Botham KM, Mayes PA, Harper's Illustrated Biochemistry Boston, U.S.A: McGraw Hill, Murray RK, Granner DK, Rodwell VW, 27 2006 209 216 23321705
32. Metabolism of lipids. 1. Fatty acids. Mayes PA, Review of Physiological Chemistry San Franscisco. Lange, Harper HA, Rodwell VW, Mayes PA, 17 1979 321 342
33. Drug-induced phospholipidosis: are there functional consequences? Reasor MJ, Kacew S, Exp Biol Med 2001 226 9 825 830 (Pubitemid 34053231)
34. A toxicogenomic approach to drug-induced phospholipidosis; analysis of its induction mechanism and establishment of a novel in-vitro screening system. Sawada H, Takami K, Asahi S, Toxicol Sci 2005 83 282 292 15342952 (Pubitemid 40227898)
35. A role for lysosomal phospholipase A2 in drug-induced phospholipidosis. Abe A, Hiraoka M, Shayman JA, Drug Met Lett 2007 1 49 53 10.2174/ 187231207779814292
36. Cholesterol-lowering effects of probiotics and prebiotics: a review of in-vivo and in-vitro findings. Ooi LG, Liong MT, Int J Mol Sci 2010 11 2499 2522 10.3390/ijms11062499 20640165